FDA approves Isembyld (Apitegromab-Mstn) for Scholar Rock, 11 Sep 2026
US FDA (Drugs@FDA), 11 Sep 2026
Drugs@FDA lists Isembyld (Apitegromab-Mstn 150MG/3ML (50MG/ML))…
Does this match what teams working with Scholar Rock are seeing?
ENCLAI Daily → enclai.net/news
#ClinicalResearch #Pharma #MedSky
